DARE - CIK 0001401914
The table below shows Dare Bioscience, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $18.52M | $23.08M | $5.04M | $10.33M | $11.23M | $16.41M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $21.66M |
| $25.00M |
| $6.60M |
| $11.82M |
| $14.95M |
| $20.83M |
| Property, plant & equipment | $1.45M | $1.66M | $1.65M | $1.48M | $706.26K | $322.28K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $27.83M | $30.75M | $12.98M | $18.62M | $18.06M | $23.61M |
| Accounts payable | $1.23M | $1.84M | $1.76M | $1.88M | $1.05M | $1.91M |
| Total current liabilities | $21.12M | $21.22M | $19.22M | $21.19M | $13.16M | $14.59M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $27.09M | $27.89M | $25.71M | $28.18M | $19.54M | $20.93M |
| Retained earnings | -$191.69M | -$187.25M | -$183.68M | -$179.67M | -$169.78M | -$165.08M |
| Total equity | $734.45K | $2.86M | -$12.73M | -$9.56M | -$1.48M | $2.67M |